Vimarsana
Biggest News Aggregation in the World

Its Pharmaceuticals News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Its Pharmaceuticals. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Its Pharmaceuticals Today - Breaking & Trending Today

Nippon Paint (OTCMKTS:NPCPF) & Sumitomo Chemical (OTCMKTS:SOMMY) Financial Review - Vimarsana News

Nippon Paint (OTCMKTS:NPCPF) & Sumitomo Chemical (OTCMKTS:SOMMY) Financial Review

Nippon Paint (OTCMKTS:NPCPF – Get Rating) and Sumitomo Chemical (OTCMKTS:SOMMY – Get Rating) are both construction companies, but which is the superior investment? We will contrast the two companies based on the strength of their analyst recommendations, dividends, earnings, profitability, valuation, institutional ownership and risk. Analyst Recommendations This is a summary of current ratings for […]

Pharma Stock Roundup: JNJ's Q1 Earnings & Sales Beat, RHHBY Sales, & Other Updates - Vimarsana News

Pharma Stock Roundup: JNJ's Q1 Earnings & Sales Beat, RHHBY Sales, & Other Updates

Pharma Stock Roundup: JNJ's Q1 Earnings & Sales Beat, RHHBY Sales, & Other Updates Zacks.com 2 hrs ago J&J JNJ announced strong first-quarter results, beating estimates for both earnings and sales. Roche’s RHHBY COVID-19 diagnostics tests sales boosted the top line, offsetting declines in its core drug business. The FDA granted approval to Glaxo’s GSK endometrial cancer therapy, Jemperli (dostarlimab). Recap of the Week’s Most Important Stories J&J Earnings & Sales Beat: J&J beat first-quarter estimates for earnings as well as sales. Its Pharmaceuticals unit continued to perform ab...

Source: msn.com